Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping ...

A research team led by Prof. Wang Hongzhi at the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has found ...

This study investigates the role of centrosomal protein CEP55 in immune evasion by liver cancer cells and evaluates the effects of its knockout using CRISPR-Cas9 technology. CEP55-knockout models were ...

Source of circulating ACBP/DBI in liver disease: Plasma ACBP/DBI levels are elevated in fatty liver disease, fibrosis, and hepatocellular carcinoma. However, the relative contributions of normal ...

Semin Liver Dis. 2013;33(3):236-247. Focal nodular hyperplasia has no malignant potential and usually remains stable or decreases in size over time. Less than 20% of patients with FNH develop symptoms ...

Forty-seven patients received intended complete treatment to 91 liver tumors. Three total complications were observed: two cases of skin irritation treated with topical ointment and one case of ...

The prestigious journal Hepatology Communications reports on the discovery by the Cancer and Translational Medicine research group of the University of the Basque Country (EHU). Tests on mice revealed ...